Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
FDA Approves First COVID-19 Treatment for Use in Children
Veklury had already been fully approved to treat people 12 years and older
White House Moves to Make COVID-19 Antiviral Pills More Widely Available
Many Americans have said they cannot find a doctor to prescribe Paxlovid or a pharmacy that has it